Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Dec;80(6):1607–1612. doi: 10.1172/JCI113247

Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.

C Boitard 1, G Feutren 1, L Castano 1, M Debray-Sachs 1, R Assan 1, J Hors 1, J F Bach 1
PMCID: PMC442429  PMID: 3316278

Abstract

Anti-islet cell and anti-insulin antibody production was studies over a 12-mo period in 82 recently diagnosed diabetics randomly receiving either cyclosporin or placebo. Cyclosporin had only minimal effects on the production of anti-islet cell antibodies whether directed to islet cytoplasmic (immunofluorescence) or membrane (cytotoxicity assay) antigens even in patients undergoing remission. These data suggest that these antibodies do not play a major role in the pathogenesis of the disease particularly since their (irregular) presence is not predictive of the clinical response to cyclosporin. Conversely, cyclosporin completely suppressed the synthesis of antibodies elicited by exogenous insulin irrespective of the insulin doses received, and decreased the autoantibody production against thyroid antigens, indicating that cyclosporin has variable effects on antibody production against various antigens.

Full text

PDF
1607

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assan R., Feutren G., Debray-Sachs M., Quiniou-Debrie M. C., Laborie C., Thomas G., Chatenoud L., Bach J. F. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet. 1985 Jan 12;1(8420):67–71. doi: 10.1016/s0140-6736(85)91964-6. [DOI] [PubMed] [Google Scholar]
  2. Bendtzen K., Mandrup-Poulsen T., Nerup J., Nielsen J. H., Dinarello C. A., Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science. 1986 Jun 20;232(4757):1545–1547. doi: 10.1126/science.3086977. [DOI] [PubMed] [Google Scholar]
  3. Boitard C., Chatenoud L. M., Debray-Sachs M. In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol. 1982 Dec;129(6):2529–2531. [PubMed] [Google Scholar]
  4. Boitard C., Saï P., Debray-Sachs M., Assan R., Hamburger J. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets. Clin Exp Immunol. 1984 Mar;55(3):571–580. [PMC free article] [PubMed] [Google Scholar]
  5. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  6. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  7. Bottazzo G. F., Dean B. M., Gorsuch A. N., Cudworth A. G., Doniach D. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet. 1980 Mar 29;1(8170):668–672. [PubMed] [Google Scholar]
  8. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  9. Bottazzo G. F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974 Nov 30;2(7892):1279–1283. doi: 10.1016/s0140-6736(74)90140-8. [DOI] [PubMed] [Google Scholar]
  10. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  11. Deschamps I., Lestradet H., Bonaïti C., Schmid M., Busson M., Benajam A., Marcelli-Barge A., Hors J. HLA genotype studies in juvenile insulin-dependent diabetes. Diabetologia. 1980 Sep;19(3):189–193. doi: 10.1007/BF00275267. [DOI] [PubMed] [Google Scholar]
  12. Dobersen M. J., Scharff J. E., Ginsberg-Fellner F., Notkins A. L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1980 Dec 25;303(26):1493–1498. doi: 10.1056/NEJM198012253032601. [DOI] [PubMed] [Google Scholar]
  13. Dongworth D. W., Klaus G. G. Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies. Eur J Immunol. 1982 Dec;12(12):1018–1022. doi: 10.1002/eji.1830121207. [DOI] [PubMed] [Google Scholar]
  14. Dos Reis G. A., Shevach E. M. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell. J Immunol. 1982 Dec;129(6):2360–2367. [PubMed] [Google Scholar]
  15. Drachman D. B., Adams R. N., McIntosh K., Pestronk A. Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol. 1985 Feb;34(2):174–188. doi: 10.1016/0090-1229(85)90022-4. [DOI] [PubMed] [Google Scholar]
  16. Feutren G., Papoz L., Assan R., Vialettes B., Karsenty G., Vexiau P., Du Rostu H., Rodier M., Sirmai J., Lallemand A. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet. 1986 Jul 19;2(8499):119–124. doi: 10.1016/s0140-6736(86)91943-4. [DOI] [PubMed] [Google Scholar]
  17. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965 Oct;14(10):619–633. doi: 10.2337/diab.14.10.619. [DOI] [PubMed] [Google Scholar]
  18. Jaworski M. A., Honore L., Jewell L. D., Mehta J. G., McGuire-Clark P., Schouls J. J., Yap W. Y. Cyclosporin prophylaxis induces long-term prevention of diabetes, and inhibits lymphocytic infiltration in multiple target tissues in the high-risk BB rat. Diabetes Res. 1986 Jan;3(1):1–6. [PubMed] [Google Scholar]
  19. Klaus G. G., Hawrylowicz C. M. Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine. Eur J Immunol. 1984 Mar;14(3):250–254. doi: 10.1002/eji.1830140309. [DOI] [PubMed] [Google Scholar]
  20. Kunkl A., Klaus G. G. Selective effects of cyclosporin A on functional B cell subsets in the mouse. J Immunol. 1980 Dec;125(6):2526–2531. [PubMed] [Google Scholar]
  21. Kurtz A. B., Matthews J. A., Mustaffa B. E., Daggett P. R., Nabarro J. D. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia. 1980;18(2):147–150. doi: 10.1007/BF00290492. [DOI] [PubMed] [Google Scholar]
  22. Larsson E. L. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980 Jun;124(6):2828–2833. [PubMed] [Google Scholar]
  23. Laupacis A., Stiller C. R., Gardell C., Keown P., Dupre J., Wallace A. C., Thibert P. Cyclosporin prevents diabetes in BB Wistar rats. Lancet. 1983 Jan 1;1(8314-5):10–12. doi: 10.1016/s0140-6736(83)91558-1. [DOI] [PubMed] [Google Scholar]
  24. Lendrum R., Walker G., Cudworth A. G., Theophanides C., Pyke D. A., Bloom A., Gamble D. R. Islet-cell antibodies in diabetes mellitus. Lancet. 1976 Dec 11;2(7998):1273–1276. doi: 10.1016/s0140-6736(76)92033-x. [DOI] [PubMed] [Google Scholar]
  25. Like A. A., Dirodi V., Thomas S., Guberski D. L., Rossini A. A. Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol. 1984 Oct;117(1):92–97. [PMC free article] [PubMed] [Google Scholar]
  26. Lillehoj H. S., Malek T. R., Shevach E. M. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens. J Immunol. 1984 Jul;133(1):244–250. [PubMed] [Google Scholar]
  27. Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C. A., Svenson M., Nielsen J. H. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia. 1986 Jan;29(1):63–67. doi: 10.1007/BF02427283. [DOI] [PubMed] [Google Scholar]
  28. Mandrup-Poulsen T., Nerup J., Stiller C. R., Marner B., Bille G., Heinrichs D., Martell R., Dupre J., Keown P. A., Jenner M. R. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics. Lancet. 1985 Mar 16;1(8429):599–602. doi: 10.1016/s0140-6736(85)92143-9. [DOI] [PubMed] [Google Scholar]
  29. McGregor A. M., Rennie D. P., Weetman A. P., Hassman R. A., Foord S. M., Dieguez C., Hall R. The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat. Life Sci. 1983 Jan 3;32(1-2):97–108. doi: 10.1016/0024-3205(83)90177-7. [DOI] [PubMed] [Google Scholar]
  30. Mori Y., Suko M., Okudaira H., Matsuba I., Tsuruoka A., Sasaki A., Yokoyama H., Tanase T., Shida T., Nishimura M. Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia. 1986 Apr;29(4):244–247. doi: 10.1007/BF00454884. [DOI] [PubMed] [Google Scholar]
  31. Muraguchi A., Butler J. L., Kehrl J. H., Falkoff R. J., Fauci A. S. Selective suppression of an early step in human B cell activation by cyclosporin A. J Exp Med. 1983 Sep 1;158(3):690–702. doi: 10.1084/jem.158.3.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nerup J., Binder C. Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. Acta Endocrinol (Copenh) 1973 Feb;72(2):279–286. doi: 10.1530/acta.0.0720279. [DOI] [PubMed] [Google Scholar]
  33. Nussenblatt R. B., Rodrigues M. M., Wacker W. B., Cevario S. J., Salinas-Carmona M. C., Gery I. Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest. 1981 Apr;67(4):1228–1231. doi: 10.1172/JCI110138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Palacios R. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J Immunol. 1982 Jan;128(1):337–342. [PubMed] [Google Scholar]
  35. Palestine A. G., Roberge F., Charous B. L., Lane H. C., Fauci A. S., Nussenblatt R. B. The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J Clin Immunol. 1985 Mar;5(2):115–121. doi: 10.1007/BF00915009. [DOI] [PubMed] [Google Scholar]
  36. Palmer J. P., Asplin C. M., Clemons P., Lyen K., Tatpati O., Raghu P. K., Paquette T. L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 1983 Dec 23;222(4630):1337–1339. doi: 10.1126/science.6362005. [DOI] [PubMed] [Google Scholar]
  37. Pilcher C., Elliott R. B. Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics. Lancet. 1984 Jun 16;1(8390):1352–1352. doi: 10.1016/s0140-6736(84)91842-7. [DOI] [PubMed] [Google Scholar]
  38. Riley W. J., Toskes P. P., Maclaren N. K., Silverstein J. H. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes. 1982 Dec;31(12):1051–1055. doi: 10.2337/diacare.31.12.1051. [DOI] [PubMed] [Google Scholar]
  39. Sibley R. K., Sutherland D. E., Goetz F., Michael A. F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest. 1985 Aug;53(2):132–144. [PubMed] [Google Scholar]
  40. Stiller C. R., Dupré J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., von Graffenried B., Wolfe B. M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984 Mar 30;223(4643):1362–1367. doi: 10.1126/science.6367043. [DOI] [PubMed] [Google Scholar]
  41. Thivolet J., Barthelemy H., Rigot-Muller G., Bendelac A. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet. 1985 Feb 9;1(8424):334–335. doi: 10.1016/s0140-6736(85)91099-2. [DOI] [PubMed] [Google Scholar]
  42. Versluis D. J., Beyer W. E., Masurel N., Wenting G. J., Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation. 1986 Oct;42(4):376–379. doi: 10.1097/00007890-198610000-00009. [DOI] [PubMed] [Google Scholar]
  43. Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 1986 Aug;35(8):855–860. doi: 10.2337/diab.35.8.855. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES